Skip to main content

Chemistry of GABAB Modulators

  • Chapter

Part of the book series: The Receptors ((REC))

Abstract

An important step toward understanding the diverse roles of the ubiquitous inhibitory neurotransmitter g-aminobutyric acid (GABA) was Bowery’s discovery that baclofen 1 (Fig. 1) stereospecifically decreases neurotransmitter release in the mammalian central nervous system (CNS) by action at a novel GABA receptor, an effect that was not blocked by bicuculline or other GABA antagonists (Bowery et al., 1980; Hill and Bowery, 1981).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abbenante, G. and Prager, R. H. (1990) Synthesis of 3-amino-2-(4-chlorophenyl)propanesulfonic acid (Saclofen) and 3-amino-2-(4-chlorophenyl)-2-hydroxypropanesulfonic acid (Hydroxysaclofen). Aust. J Chem. 43, 213, 214.

    Google Scholar 

  • Abbenante, G. and Prager, R. H. (1992a) Potential GABAB receptor antagonists. VI. The synthesis of saclofen and other sulfonic acid derivatives. Aust. J Chem. 45, 1801 1810.

    Google Scholar 

  • Abbenante, G. and Prager, R. H. (1992b) Potential GABAB receptor antagonists. V. The application of radical additions to styrenes to produce 2-hydroxysaclofen. Aust. J. Chem. 45, 1791–1800.

    CAS  Google Scholar 

  • Allan, R. D., Bates, M. C., Drew, C. A., Duke, R. K., Hambley, T. W., Johnston, G. A. R., Mewitt, K. N., and Spence, I. (1990) A new synthesis, resolution and in vitro activities of (R)- and (S)-ß-phenyl-GABA. Tetrahedron 46, 2511–2524.

    Article  CAS  Google Scholar 

  • Baylis, E. K., Campbell, C. D., and Dingwall, J. G. (1984) 1-Aminoalkylphosphonous acids. Part 1. Isosteres of the protein amino acids. J Chem. Soc. Perkin Trans. I, 2845–2853.

    Google Scholar 

  • Beattie, D. T., Curtis, D. R., Debaert, M., Vaccher, C., and Berthelot, P. (1989) Baclofen antagonism by 4-amino-3-(5-methoxybenzo[b]furan-2-yl)-butanoic acid in the cat spinal cord. Neurosci. Lett. 100, 292–294.

    Article  PubMed  CAS  Google Scholar 

  • Belakhov, V. V., Yudelevich, V. I., Komarov, E. V., Ionin, B. I., Komarov, V. Y., Zakharov, V. I., Lebedev, V. B., and Petrov, A. A. (1983) Reactivity of hypophosphites. VI. Reactions of hypophosphorous acid with acetylenic alcohols. Zh. Obshch. Khim. 53, 1493–1503. J. Gen. Chem. USSR (Engi. Transi.) 53, 1345–1353. Chem. Abstr. 99, 21 2598v.

    Google Scholar 

  • Bernasconi, R., Mathivet, P., Marescaux, C., Leonhardt, T., Martin, P., Mickel, S., and Froestl, W. (1994) NMDA receptors and NO synthase (NOS) are involved in the increase of cerebral cGMP induced by GABAB antagonists. Br. J. Pharmacoi. 112 (Suppl.), 7 P.

    Google Scholar 

  • Berthelot, P., Vaccher, C., Flouquet, N., Debaert, M., Luyckx, M., and Brunet, C. (1991) 3-Thienyl-and 3-Furylaminobutyric acids. Synthesis and binding GABAB receptor studies. J. Med. Chem. 34, 2557–2560

    Google Scholar 

  • Berthelot, P., Vaccher, C., Musadad, A., Flouquet, N., Debaert, M., and Luyckx, M. (1987) Synthesis and pharmacological evaluation of y-aminobutyric acid analogues. New ligand for GABAB sites. J. Med. Chem. 30, 743–746.

    Article  PubMed  CAS  Google Scholar 

  • Bittiger, H., Bernasconi, R., Froestl, W., Hall, R., Jaekel, J., Klebs, K., Krueger, L., Mickel, S. J., Mondaori, C., Olpe, H.-R., Pfannkuch, F., Pozza, M., Probst, A., van Riezen, H., Schmutz, M., Schuetz, H., Steinmann, M. W., Vassout, A., Waldmeier, P., Bieck, P., Farger, G., Gleiter, C., Schmidt, E. K., and Marescaux, C. (1992a) GABAB antagonists: potential new drugs. Pharmacol. Commun. 2, 70–74.

    Google Scholar 

  • Bittiger, H., Froestl, W., Hall, R., Karlsson, G., Klebs, K., Olpe, H.-R., Pozza, M. F., Steinmann, M. W., and Van Riezen, H. (1990) Biochemistry, electrophysiology and pharmacology of a new GABAB antagonist: CGP35348, in GABA B Receptors in Mammalian Function (Bowery, N. G., Bittiger, H., and Olpe, H.-R., Eds.), John Wiley, Chichester, UK, pp. 47–60.

    Google Scholar 

  • Bittiger, H., Froestl, W., Mickel, S. J., and Olpe, H.-R. (1993) GABAB receptor antagonists: from synthesis to therapeutic applications. Trends Pharmacol. Sci. 14, 391–394.

    Article  PubMed  CAS  Google Scholar 

  • Bittiger, H., Reymann, N., Froestl, W., and Mickel, S. J. (1992b) [3H]CGP54626: a potent antagonist radioligand for GABAB receptors. Pharmacol. Commun. 2, 23.

    Google Scholar 

  • Bittiger, H., Reymann, N., Hall, R., and Kane, P. (1988) CGP27492, a new potent and selective radioligand for GABAB receptors. Eur. J. Neurosci. Suppl., Abstr. 16. 10.

    Google Scholar 

  • Blake, J. F., Cao, C. Q., Headley, P. M., Collingridge, G. L., Brugger, F., and Evans, R. H. (1993) Antagonism of baclofen-induced depression of whole-cell synaptic currents in spinal dorsal horn neurones by the potent GABAB antagonist CGP55845. Neuropharmacology 32, 1437–1440.

    Google Scholar 

  • Bolser, D. C., Blythin, D. J., Chapman, R. W., Egan, R. W., Hey, J. A., Rizzo, C., Kuo, S.-C., and Kreutner, W. (1995) The pharmacology of SCH 50911: a novel, orally-active GABA-B receptor antagonist. J. Pharm. Exp. Ther. 274, 1393–1398.

    CAS  Google Scholar 

  • Bonanno, G. and Raiteri, M. (1993) Multiple GABAB receptors. Trends Pharmacol. Sci. 14, 259–261.

    Article  PubMed  CAS  Google Scholar 

  • Bowery, N. G., Hill, D. R., Hudson, A. L., Doble, A., Middlemiss, D. N., Shaw, J., and Turnbull, M. (1980) (—) Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature (London) 283, 92–94.

    Google Scholar 

  • Brugger, F., Wicki, U., Olpe, H.-R., Froestl, W., and Mickel, S. (1993) The action of new potent GABAB receptor antagonists in the hemisected spinal cord preparation of the rat. Eur. J. Pharmacol. 235, 153–155.

    Article  PubMed  CAS  Google Scholar 

  • Caddick, S. J., Stanford, I. M., and Chad, J. E. (1995) 2-Hydroxy-saclofen causes a phaclofen-reversible reduction in population spike amplitude in the rat hippocampal slice. Eur. J. Pharmacol. 274, 41–46.

    Google Scholar 

  • Carletti, R., Libri, V., and Bowery, N. G. (1993) The GABAB antagonist CGP36742 enhances spatial learning performance and antagonises baclofen-induced amnesia in mice. Br. J. Pharmacol. 109 (Suppl.), 74 P.

    Google Scholar 

  • Carruthers, N. I., Spitler, J. M., Wong, S.-C., Blythin, D. J., Chen, X., Shue, H.-J., and Mittelman, S. (1995) Synthesis and resolution of ß-(aminomethyl)-4-chlorobenzeneethanesulfinic acid. A potent GABAB receptor ligand. Bioorg. Med. Chem. Lett. 5, 237–240.

    Google Scholar 

  • Chiefari, J., Galanopoulos, S., Janowski, W. K., Kerr, D. I. B., and Prager, R. H. (1987) The synthesis of phosphonobaclofen, an antagonist of baclofen. Austr. J. Chem. 40, 1511–1518.

    Article  CAS  Google Scholar 

  • Curtis, D. R., Gynther, B. D., Beattie, D. T., Kerr, D. I. B., and Prager, R. H. (1988) Baclofen antagonism by 2-hydroxy-saclofen in the cat spinal cord. Neurosci. Lett. 92, 97–101.

    Google Scholar 

  • Davies, C. H., Pozza, M. F., and Collingridge, G. L. (1993) CGP55845A: a potent antagonist of GABAB receptors in the CAI region of rat hippocampus. Neuropharmacology 32, 1071–1073.

    Google Scholar 

  • Debaert, M., Berthelot, P., and Vaccher, C. (1992) Nouveau composés de l’acide 4-amino butyrique leur procédé de préparation et les préparations pharmaceutiques qui les contiennent. Eur. Pat. Appl. 463 969 Al; prior: 27 June 1990.

    Google Scholar 

  • Dickenson, H. W., Allan, R. D., Ong, J., and Johnston, G. A. R. (1988) GABAB receptor antagonist and GABAA receptor agonist properties of a S-aminovalerianic acid derivative, Z-5-aminopent-2-enoic acid. Neurosci. Lett. 86, 351–355.

    Article  PubMed  CAS  Google Scholar 

  • Dingwall, J. G., Ehrenfreund, J., and Hall, R. G. (1989) Diethoxymethylphosphonites and phosphinates. Intermediates for the synthesis of a, ß-and y-aminoalkyl-phosphonous acids. Tetrahedron 45, 3787–3808.

    Article  CAS  Google Scholar 

  • Dingwall, J. G., Ehrenfreund, J., Hall, R. G., and Jack, J. (1987) Synthesis of y-aminopropylphosphonous acids using hypophosphorous acid synthons. Phosphorus Sulfur 30, 571–574.

    Google Scholar 

  • Drew, C. A., Johnston, G. A. R., Kerr, D. I. B., and Ong, J. (1990) Inhibition of baclofen binding to rat cerebellar membranes by phaclofen, saclofen, 3-aminopropylphosphonic acid and related GABAB receptor antagonists. Neurosci. Lett. 113, 107–110.

    Article  PubMed  CAS  Google Scholar 

  • Falch, E., Hedegaard, A., Nielsen, L., Jensen, B. R., Hjeds, H., and Krogsgaard-Larsen, P. (1986) Comparative stereostructure-activity studies on GABAA and GABAB receptor sites and GABA uptake using rat brain membrane preparations. J. Neurochem. 47, 898–903.

    Article  PubMed  CAS  Google Scholar 

  • Froestl, W., Furet, P., Hall, R. G., Mickel, S. J., Strub, D., von Sprecher, G., Baumann, P. A., Bemasconi, R., Brugger, F., Felner, A., Gentsch, C., Hauser, K., Jaekel, J., Karlsson, G., Klebs, K., Maître, L., Marescaux, C., Moser, P., Pozza, M. F., Rihs, G., Schmutz, M., Steinmann, M. W., van Riezen, H.,Vassout, A., Mondadori, C., Olpe, H.-R., Waldmeier, P. C., and Bittiger, H. (1993a) GABAB antagonists: novel CNS-active compounds, in Perspectives in Medicinal Chemistry ( Testa, B., Kyburz, E., Fuhrer, W., and Giger, R., eds.), Verlag Helvetica Chimica Acta, Basel, pp. 259–272.

    Google Scholar 

  • Froestl, W., Mickel, S. J., and Bittiger, H. (1993b) Potent GABAB agonists and antagonists. Curr Opin. Ther. Pat. 3, 561–567.

    Article  Google Scholar 

  • Froestl, W., Mickel, S. J., Hall, R. G., von Sprecher, G., Strub, D., Baumann, R A., Brugger, F., Gentsch, C., Jaekel, J., Olpe, H.-R., Rihs, G., Vassout, A., Waldmeier, P. C., and Bittiger, H. (1995a) Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists. J. Med. Chem. 38, 3297–3312.

    Article  PubMed  CAS  Google Scholar 

  • Froestl, W., Mickel, S. J., von Sprecher, G., Bittiger, H., and Olpe, H.-R. (1992) Chemistry of new GABAB antagonists. Pharmacol. Commun. 2, 52–56.

    CAS  Google Scholar 

  • Froestl, W., Mickel, S. J., von Sprecher, G., Diel, R J., Hall, R. G., Maier, L., Strub, D., Melillo, V, Baumann, P. A., Bemasconi, R., Gentsch, C., Hauser, K., Jaekel, J., Karlsson, G., Klebs, K., Maltre, L., Marescaux, C., Pozza, M. F., Schmutz, M., Steinmann, M. W., van Riezen, H., Vassout, A., Mondadori, C., Olpe, H.-R., Waldmeier P. C., and Bittiger, H. (1995b) Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists. J. Med. Chem. 38, 3313–3331.

    Google Scholar 

  • Fromm, G. H. (1991) Medical treatment of patients with trigeminal neuralgia, in Trigeminal Neuralgia. Current Concepts Regarding Pathogenesis and Treatment ( Fromm, G. H. and Sessle, B. J., eds.), Butterworth-Heinemann, Boston, pp. 131–144.

    Google Scholar 

  • Frydenvang, K., Hansen, J. J., Krogsgaard-Larsen, P., Mitrovic, A., Tran, H., Drew, C. A., and Johnston, G. A. R. (1994) GABAB antagonists: resolution, absolute stereochemistry, and pharmacology of (R)- and (S)-phaclofen. Chirality 6, 583–589.

    Article  PubMed  CAS  Google Scholar 

  • Gallagher, M. J. and Honegger, H. (1980) Organophosphorus intermediates. VI. The acid catalysed reaction of trialkyl orthoforrnates with phosphinic acid. Aust. J. Chem. 33, 287–294.

    Article  CAS  Google Scholar 

  • Gemignani, A., Paudice, P., Bonanno, G., and Raiteri, M. (1994) Pharmacological discrimination between y-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes. Mol. Pharmacol. 46, 558–562.

    PubMed  CAS  Google Scholar 

  • Hall, R. G. (1989) An efficient synthesis of (±)-3-amino-2-(4-chlorophenyl)-propylphosphonic acid (PHACLOFEN). Synthesis 1989, 442, 443.

    Google Scholar 

  • Hall, R. G., Kane, P. D., Bittiger, H., and Froestl, W. (1995) Phosphinic acid analogues of y-aminobutyric acid (GABA). Synthesis of a new radioligand. J. Labelled Compd. Radiopharm. 36, 129–135.

    Article  CAS  Google Scholar 

  • Herdeis, C. and Hubmann, H. P. (1992) Synthesis of homochiral R-baclofen from S-glutamic acid. Tetrahedron Asymm. 3, 1213–1221.

    Article  CAS  Google Scholar 

  • Herranz, E., Biller, S. A., and Sharpless, K. B. (1978) Osmium-catalyzed vicinal oxyamin-ation of olefins by N-chloro-N-argentocarbamates. J. Amer. Chem. Soc. 100, 3596–3598.

    Article  CAS  Google Scholar 

  • Hill, D. R. and Bowery, N. G. (1981) 3H-Baclofen and 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain. Nature (London) 290, 149–152.

    Google Scholar 

  • Hosford, D. A., Clark, S., Cao, Z., Wilson, W. A., Lin, F., Morrisett, R. A., and Huin, A. (1992) The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science 257, 398–401.

    Article  PubMed  CAS  Google Scholar 

  • Hosford, D. A., Wang, Y., Liu, C. C., and Snead, C. O. (1995) Characterization of the antiabsence effects of SCH 50911, a GABAB receptor antagonist, in the lethargic mouse, y-hydroxybutyrate, and pentylenetetrazole models. J. Pharm. Exp. Ther. 274, 1399–1403.

    Google Scholar 

  • Howson, W., Mistry, J., Broekman, M., and Hills, J. M. (1993) Biological activity of 3-aminopropyl (methyl) phosphinic acid, a potent and selective GABAB agonist with CNS activity. Bioorg. Med. Chem. Lett. 3, 515–518.

    Article  CAS  Google Scholar 

  • Jarolimek, W., Demmelhuber, J., Bijak, M., and Misgeld, U. (1993) CGP55845A blocks baclofen, y-aminobutyric acid and inhibitory postsynaptic potassium currents in guinea pig CA3 neurons. Neurosci. Lett. 154, 31–34.

    Article  PubMed  CAS  Google Scholar 

  • Johnston, G. A. R. (1994) GABA receptors: as complex as ABC? Clin. Exp. Pharmacol. Physiol. 21, 521–526.

    Article  PubMed  CAS  Google Scholar 

  • Johnston, G. A. R., Curtis, D. R., Beart, P. M., Game, C. J. A., McCulloch, R. M., and Twitchin, B. (1975) Cis-and Trans-4-aminocrotonic acid as GABA analogues of restricted conformation. J. Neurochem. 24, 157–160.

    CAS  Google Scholar 

  • Keberle, H., Faigle, J. W., and Wilhelm, M. (1968) Procedure for the preparation of new aminoacids. Swiss Patent 449 046, 1968; prior: 9 July 1963. Chem. Abstr. 69, 106273f.

    Google Scholar 

  • Kerr, D. I. B. and Ong, J. (1992) GABA agonists and antagonists. Med. Res. Rev. 12, 593–636.

    Google Scholar 

  • Kerr, D. I. B., Ong, J., Doolette, D. J., Schafer, K., and Prager, R. H. (1995) (S)-enantiomer of 2-hydroxysaclofen is the active GABAB receptor antagonist in central and peripheral preparations. Eur. J. Pharmacol. 287, 185–189.

    Google Scholar 

  • Kerr, D. I. B., Ong, J., Johnston, G. A. R., Abbenante, J., and Prager, R. H. (1988) 2-Hydroxysaclofen: an improved antagonist at central and peripheral GABAB receptors. Neurosci. Lett. 92, 92–96.

    Google Scholar 

  • Kerr, D. I. B., Ong, J., Johnston, G. A. R., Abbenante, J., and Prager, R. H. (1989a) Antagonism at GABAB receptors by saclofen and related sulphonic analogues of baclofen and GABA. Neurosci. Lett. 107, 239–244.

    Article  PubMed  CAS  Google Scholar 

  • Kerr, D. I. B., Ong, J., Johnston, G. A. R., Berthelot, P., Debaert, M., and Vaccher, C. (1989b) Benzofuran analogues of baclofen: a new class of central and peripheral GABAB-receptor antagonists. Eur. J. Pharmacol. 164, 361–364.

    Article  PubMed  CAS  Google Scholar 

  • Kerr, D. I. B., Ong, J., Prager, R. H., Gynther, B. D., and Curtis, D. R. (1987) Phaclofen: a peripheral and central baclofen antagonist. Brain Res. 405, 150–154.

    Article  PubMed  CAS  Google Scholar 

  • Klebs, K., Bittiger, H., Froestl, W., Glatt, A., Hafner, T., Mickel, S., Olpe, H.-R., and Schmutz, M. (1992) GABAB antagonists and anti-absence drugs suppress gammabutyrolactone induced delta waves: a model for testing anti-absence drugs. Pharmacol. Commun. 2, 171–172.

    Google Scholar 

  • Kristiansen, U., Hedegaard, A., Herdeis, C., Lund, T. M., Nielsen, B., Hansen, J. J., Falch, E., Hjeds, H., and Krogsgaard-Larsen, P. (1992) Hydroxylated analogues of 5aminovaleric acid as 4-aminobutyric acidB receptor antagonists: stereostructureactivity relationships. J. Neurochem. 58, 1150–1159.

    Article  PubMed  CAS  Google Scholar 

  • Kuo, S.-C., Blythin, D. J., and Kreutner, W. (1994) 2-Substituted morpholine and thiomorpholine derivatives as GABAB antagonists. WO 22843; prior: 26 March 1993.

    Google Scholar 

  • Lacey, G. and Curtis, D. R. (1994) Phosphinic acid derivatives as baclofen agonists and antagonists in the mammalian spinal cord: an in vivo study. Exp. Brain Res. 101, 59–72.

    Article  PubMed  CAS  Google Scholar 

  • Lambert, N. A. and Wilson, W. A. (1993) Heterogeneity in presynaptic regulation of GABA release from hippocampal inhibitory neurons. Neuron 11, 1057–1067.

    Article  PubMed  CAS  Google Scholar 

  • Lanza, M., Fassio, A., Gemignani, A., Bonanno, G., and Raiteri, M. (1993) CGP52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur. J. Pharmacol. 237, 191–195.

    Article  PubMed  CAS  Google Scholar 

  • Li, C.-S., Howson, W., and Dolle, R. E. (1991) Synthesis of (±)-3-amino-2-(4chlorophenyl)propanesulfonic acid ( Saclofen ). Synthesis 1991, 244.

    Google Scholar 

  • Lingenhoehl, K. and Olpe, H.-R. (1993) Blockade of the late inhibitory postsynaptic potential in vivo by the GABAB blocker CGP46381. Pharmacol. Commun. 3, 49–54.

    CAS  Google Scholar 

  • Mann, A., Boulanger, T., Brandau, B., Durant, F., Evrard, G., Heaulme, M., Desaulles, E., and Wermuth, C.-G. (1991) Synthesis and biochemical evaluation of baclofen analogues locked in the baclofen solid-state conformation. J. Med. Chem. 34, 1307 1313.

    Google Scholar 

  • Marescaux, C., Liu, Z., Bernasconi, R., and Vergnes, M. (1992) GABAB receptors are involved in the occurrence of absence seizures in rats. Pharmacol. Commun. 2, 57–62.

    CAS  Google Scholar 

  • Marsden, D. (1989) Treating Spasticity: Pharmacological Advances. Hans Huber, Toronto. Meyers, A. I. and Snyder, L. (1993) The synthesis of aracemic 4-substituted pyrroli-dinones and 3-substituted pyrrolidines. An asymmetric synthesis of (—)-Rolipram. J. Org. Chem. 58, 36–42.

    Google Scholar 

  • Mondadori, C., Preiswerk, G., and Jaekel, J. (1992) Treatment with a GABAB receptor blocker improves the cognitive performance of mice, rats and rhesus monkeys. Pharmacol. Commun. 2, 93–97.

    CAS  Google Scholar 

  • Mondadori, C., Jaekel, J., and Preiswerk, G. (1993) CGP36742: the first orally active GABAB blocker improves the cognitive performance of mice, rats, and rhesus monkeys. Behay. Neural Biol. 60, 62–68.

    Article  CAS  Google Scholar 

  • Muhyaddin, M., Roberts, P. J., and Woodruff, G. N. (1982) Presynaptic y-amino-butyric acid receptors in the rat anococcygeus muscle and their antagonism by 5-aminovaleric acid. Br. J. Pharmacol. 77, 163–168.

    Article  PubMed  CAS  Google Scholar 

  • Mulzer, J. (1994) Asymmetric synthesis of the novel antidepressant Rolipram. J. Prakt. Chem. 336, 287–291.

    Article  CAS  Google Scholar 

  • Ochs, G. (1993) Inthrathecal baclofen. Baillière’s Clin. Neurol. 2, 73–86.

    PubMed  CAS  Google Scholar 

  • Olpe, H.-R. Karlsson, G., Pozza, M. F., Brugger, F., Steinmann, M., Van Riezen, H.

    Google Scholar 

  • Fagg, G., Hall, R. G., Froestl, W., and Bittiger, H. (1990) CGP35348: a centrally active blocker of GABAB receptors. Eur. J. Pharmacol. 187, 27–38.

    Article  PubMed  Google Scholar 

  • Olpe, H.-R., Steinmann, M. W., Ferrat, T., Pozza, M. F., Greiner, K., Brugger, F., Froestl, W., Mickel, S. J., and Bittiger, H. (1993) The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro. Eur. J. Pharmacol. 233, 179–186.

    Article  CAS  Google Scholar 

  • Olpe, H.-R., Steinmann, M. W., Greiner, K., and Pozza, M. F. (1994) Contribution of presynaptic GABAB receptors to paired-pulse depression of GABA-responses in the hippocampus. Naunyn-Schmiedberg’s Arch. Pharmacol. 349, 473–477.

    Article  CAS  Google Scholar 

  • Ong, J., Kerr, D. I. B., Abbenante, J., and Prager, R. H. (1991) Short-chain baclofen analogues are GABAB receptor antagonists in the guinea-pig isolated ileum. Eur. J. Pharmacol. 205, 319–322.

    Article  PubMed  CAS  Google Scholar 

  • Ong, J., Kerr, D. I. B., Johnston, G. A. R., and Hall, R. G. (1990) Differing actions of baclofen and 3-aminopropylphosphinic acid in rat neocortical slices. Neurosci. Lett. 109, 169–173.

    Article  PubMed  CAS  Google Scholar 

  • Penn, R. D. (1992) Inthrathecal baclofen for spasticity of spinal origin: seven years of experience. J. Neurosurg. 77, 236–240.

    Article  PubMed  CAS  Google Scholar 

  • Penn, R. D., Savoy, S. M., Corcos, D., Latash, M., Gottlieb, G., Parke, B., and Kroin, J. S. (1989) Intrathecal baclofen for severe spasticity. N. Engl. J. Med. 320, 1517–1521.

    Article  PubMed  CAS  Google Scholar 

  • Prager, R. H., Schafer, K., Hamon, D. P. G., and Massy-Westropp, R. A. (1995) The synthesis of (R)-(—) and (S)-(+)-hydroxysaclofen. Tetrahedron 51, 11, 465–11, 472.

    Google Scholar 

  • Pratt, G. D., Knott, C., Davey, R., and Bowery, N. G. (1989) Characterisation of 3-aminopropyl phosphinic acid (3-APPA) as a GABAB agonist in rat brain tissue. Br. J. Pharmacol. 96 (Suppl.), 141 P.

    Google Scholar 

  • Robinson, T. N., Cross, A. J., Green, A. R., Toczek, J. M., and Boar, B. R. (1989) Effects of the putative antagonists phaclofen and 6-aminovaleric acid on GABAB receptor biochemistry. Br. J. Pharmacol. 98, 833–840.

    Article  PubMed  CAS  Google Scholar 

  • Schoenfelder, A., Mann, A., and Le Coz, S. (1993) Enantioselective synthesis of (R)-(—)baclofen. Synlett 63–64.

    Google Scholar 

  • Schwartz, T. W. (1994) Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotechnol. 5, 434–444.

    Article  PubMed  CAS  Google Scholar 

  • Snead, O. C. (1992) Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures. Eur. J. Pharmacol. 213, 343–349.

    Article  PubMed  CAS  Google Scholar 

  • Topliss, J. G. (1972) Utilization of operational schemes for analog synthesis in drug design. J. Med. Chem. 15, 1006–1011.

    Article  PubMed  CAS  Google Scholar 

  • Turgeon, S. M. and Albin, R. L. (1994) Postnatal ontogeny of GABAB binding in rat brain. Neuroscience 62, 601–613.

    Article  PubMed  CAS  Google Scholar 

  • Vaccher, C., Berthelot, P., and Debaert, M. (1993a) Direct separation of 4-amino-3-(4chlorophenyl)butyric acid and analogues, GABAB ligands, using a chiral crown ether stationary phase../. Chromatogr. 645, 95–99.

    Article  CAS  Google Scholar 

  • Vaccher, C., Berthelot, P., Flouquet, N., Vaccher, M.-P., and Debaert, M. (1993b) Bromination of a-methylstyrenes with N-bromosuccinimide in chlorobenzene one-pot and selective preparation of 1,3-dibromo-2-phenylprop-1-enes. Synth. Commun. 23, 671–679.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Froestl, W., Mickel, S.J. (1997). Chemistry of GABAB Modulators. In: Enna, S.J., Bowery, N.G. (eds) The GABA Receptors. The Receptors. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4757-2597-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2597-1_10

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-2599-5

  • Online ISBN: 978-1-4757-2597-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics